Medartis Holding AG Financials

Market Capitalization CHF696.1 Million as of Jan. 1, 2025

Valuations Metrics as of Jan. 25, 2025

Trailing PE	165.16
Forward PE	51.72
Price to Sales TTM	CHF3.16
Price to Book MRQ	CHF2.54
Enterprise to Revenue	3.11
Enterprise to EBITDA	26.51

Financial Reports as of Dec. 31, 2023

Financials

Fiscal Year Ends	2023-12-31
Most Recent Quarter	2023-12-31
Profit Margin	1.83%
Operating Margin	2.44%
Return on Assets TTM	1.84%
Return on Equity TTM	1.50%

Income Statement

Revenue TTM	CHF220,282,000
Revenue per Share TTM	CHF17.04
Quarterly Revenue Growth	8.00%
Gross Profit TTM	CHF167,572,000
EBITDA	CHF25,383,000
Net Income to Common TTM	CHF4,032,000
Diluted EPS TTM	CHF0.31
Quarterly Earnings Growth YoY	%

Balance Sheet

Total Cash MRQ	CHF127,088,000
Total Cash per Share MRQ	CHF9.41
Total Debt MRQ	CHF
Total Debt to Equity MRQ	44.37
Current Ratio MRQ	4.52
Book Value per Share MRQ	CHF20.19

Cash Flow

Operating Cash Flow TTM	CHF32,198,000
Levered Free Cash Flow TTM	CHF20,465,842

MED Stock Info as of Jan. 25, 2025

Stock Statistics

Shares Outstanding	13,595,500
Float Shares	5,525,415
Avg 10 Volume	2,575
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	59.66%
% Held by Institutions	27.74%

Stock Price Summary

Beta	0.96
Fifty Two Week Low	CHF44.15
Fifty Two Week High	CHF90.00
Fifty Two Week Change	-2.10%
Day 50 MA	CHF54.52
Day 200 MA	CHF67.26

Dividends and Splits

Forward Annual Dividend Rate	CHF
Forward Annual Dividend Yield	%
Trailing Annual Dividend Rate	CHF0.00
Trailing Annual Dividend Yield	0.00%
Payout Ratio	0.00%
Dividend Date
Ex Dividend Date
Last Split Factor
Last Split Date